Patient-Friendly Explanation

Setmelanotide (brand name Imcivree) is an injectable medication that targets a specific pathway in the brain controlling hunger. It is approved for certain rare genetic forms of obesity that begin in childhood and do not respond to diet and exercise alone.

Clinical Definition

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist that restores signalling in the leptin-melanocortin pathway, which regulates energy homeostasis. It is indicated for obesity due to POMC, PCSK1, or LEPR deficiency confirmed by genetic testing, administered as a once-daily subcutaneous injection.

Why It Matters

For patients with rare genetic obesity syndromes, conventional weight loss approaches often fail. Our doctor at NuLifeCare can help determine if genetic testing and targeted therapy like setmelanotide may be appropriate for your situation.